Predicate Research Report · generated 2026-08-23 · Print / save as PDF · Save to account
Investigacion Farmaceutica S.A. DE C.V. · Predicate Candidate Screening
24 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
123 daysmedian FDA review time
246 days90th percentile
24clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K892721 | IFA SENSIBAC CEFACLOR | Investigacion Farmaceutica S.A. DE C.V. | 1989-11-30 | 230 | 0 |
| K892728 | IFA SENSIBAC NORFLOXACIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-09-21 | 160 | 0 |
| K892713 | IFA SENSIBAC NALIDIXIC ACID | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-17 | 125 | 0 |
| K892733 | IFA SENSIBAC KANAMYCIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-17 | 125 | 0 |
| K892735 | IFA SENSIBAC CEPHALOTIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-17 | 125 | 0 |
| K885110 | PROTEUS OX-19 IFA* | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-15 | 246 | 0 |
| K885112 | BRUCELLA IFA* | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-15 | 246 | 0 |
| K885113 | IFA* POSITIVE AND NEGATIVE ANTIGENS CONTROL | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-15 | 246 | 0 |
| K885114 | SALMONELLA IFA* | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-15 | 246 | 0 |
| K892720 | IFA SENSIBAC GENTAMYCIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-15 | 123 | 0 |
| K892726 | IFA SENSIBAC PENICILLIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-15 | 123 | 0 |
| K892714 | IFA SENSIBAC NEOMYCIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K892715 | IFA SENSIBAC NITROFURANTOIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K892717 | IFA SENSIBAC BACITRACIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K892718 | IFA SENSIBAC TETRACYCLINE | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K892719 | IFA SENSIBAC ERYTHROMYCIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K892722 | IFA SENSIBAC CINOXACIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K892723 | IFA SENSIBAC POLYMYXIN B | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K892724 | IFA SENSIBAC STREPTOMYCIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K892725 | IFA SENSIBAC VANCOMYCIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K892727 | IFA SENSIBAC INIPENEM | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K892729 | IFA SENSIBAC TOBRAMYCIN | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K892730 | IFA SENSIBAC CHLROAMPHENICOL | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-03 | 111 | 0 |
| K885107 | THROMBOSTIN IFA* | Investigacion Farmaceutica S.A. DE C.V. | 1989-06-23 | 193 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda